Search results
The recommended starting dose of Lantus ® in patients with type 2 diabetes who are not currently treated with insulin is 0.2 Units/kg or up to 10 Units once daily, adjusted to patient’s appropriate FPG target. One may need to adjust the amount and timing of short- or rapid-acting insulins and dosages of any oral anti-diabetic drugs
The recommended starting dose of LANTUS in patients with type 2 diabetes who are not currently treated with insulin is 0.2 units/kg or up to 10 units once daily. One may need to adjust the amount and timing of short- or rapid-acting insulins and dosages of any oral antidiabetic drugs.
Usual initial dose range: 0.2-0.4 units/kg; optimal glucose lowering effect may take 5 days to fully manifest and the first insulin glargine dose may be insufficient to cover metabolic...
Important Safety Information for Lantus (insulin glargine injection) 100 Units/mL. Do not take Lantus during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Lantus. Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles.
Warnings and precautions. Talk to your doctor, pharmacist or nurse before using Lantus. Follow closely the instructions for posology, monitoring (blood and urine tests), diet and physical activity (physical work and exercise) as discussed with your doctor.
daily regimen with Lantus should reduce their daily dose of basal insulin by 20 – 30% during the first weeks of treatment. Switch from Toujeo (insulin glargine) 300 units/ml to Lantus:
Insulin Glargine is available in 2 concentrations: 100 units/mL (U-100) and 300 units/mL (U-300) Lantus(R) U-100: Available 10 mL vials and 3 mL SoloStar pens; pen delivers doses in 1 unit increments from 1 to 80 units; doses greater than 80 units should be given as 2 or more injections.
